BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8399068)

  • 1. Bryostatin 1-induced modulation of the acute lymphoblastic leukemia cell line Reh.
    al-Katib A; Mohammad RM; Khan K; Dan ME; Pettit GR; Sensenbrenner LL
    J Immunother Emphasis Tumor Immunol; 1993 Jul; 14(1):33-42. PubMed ID: 8399068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitogen-activated protein kinase is required for bryostatin 1-induced differentiation of the human acute lymphoblastic leukemia cell line Reh.
    Wall NR; Mohammad RM; Al-Katib AM
    Cell Growth Differ; 2001 Dec; 12(12):641-7. PubMed ID: 11751459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different effects of the two protein kinase C activators bryostatin-1 and TPA on growth and differentiation of human monocytic leukemia cell lines.
    Steube KG; Grunicke D; Quentmeier H; Drexler HG
    Leuk Res; 1993 Oct; 17(10):897-901. PubMed ID: 8412301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response of Jurkat T cells to phorbol ester and bryostatin. Development of sublines with distinct functional responses and changes in protein kinase C activity.
    Levine BL; May WS; Tyler PG; Hess AD
    J Immunol; 1991 Nov; 147(10):3474-81. PubMed ID: 1834742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induced expression of a monocytoid B lymphocyte antigen phenotype on the REH cell line.
    Patel B; Mohammad RM; Blaustein J; al-Katib A
    Am J Hematol; 1990 Mar; 33(3):153-9. PubMed ID: 2105637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiation and growth modulation of myeloid leukemia cells by the protein kinase C activating agent bryostatin-1.
    Steube KG; Drexler HG
    Leuk Lymphoma; 1993 Jan; 9(1-2):141-8. PubMed ID: 8477194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different biological effects of the two protein kinase C activators bryostatin-1 and TPA on human carcinoma cell lines.
    Steube KG; Grunicke D; Drexler HG
    Invest New Drugs; 1994; 12(1):15-23. PubMed ID: 7960600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of T-cells by bryostatins: induction of the IL-2 receptor gene transcription and down-modulation of surface receptors.
    Esa AH; Boto WO; Adler WH; May WS; Hess AD
    Int J Immunopharmacol; 1990; 12(5):481-90. PubMed ID: 2210911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of gene expression in the acute promyelocytic leukemia cell line NB4.
    Hu ZB; Ma W; Uphoff CC; Lanotte M; Drexler HG
    Leukemia; 1993 Nov; 7(11):1817-23. PubMed ID: 7901456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiation and growth modulation of chronic myelogenous leukemia cells by bryostatin.
    Lilly M; Tompkins C; Brown C; Pettit G; Kraft A
    Cancer Res; 1990 Sep; 50(17):5520-5. PubMed ID: 2386956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of bryostatin on protein kinase C-regulated functions in human T lymphocytes and epidermal keratinocytes.
    Galron D; Tamir A; Gelkop S; Grossman N; Isakov N
    Immunol Lett; 1993 Dec; 39(1):17-22. PubMed ID: 8144186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bryostatins selectively regulate protein kinase C-mediated effects on GH4 cell proliferation.
    Mackanos EA; Pettit GR; Ramsdell JS
    J Biol Chem; 1991 Jun; 266(17):11205-12. PubMed ID: 1904062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of ubiquitin carboxyl terminal hydrolase in the differentiation of human acute lymphoblastic leukemia cell line, Reh.
    Maki A; Mohammad RM; Smith M; Al-Katib A
    Differentiation; 1996 Mar; 60(1):59-66. PubMed ID: 8935929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bryostatin 1 induces ubiquitin COOH-terminal hydrolase in acute lymphoblastic leukemia cells.
    Mohammad RM; Maki A; Pettit GR; al-Katib AM
    Enzyme Protein; 1996; 49(5-6):262-72. PubMed ID: 9252784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of differentiation of B-cell leukemia cell lines JVM-2 and EHEB by bryostatin 1.
    Hu ZB; Gignac SM; Uphoff CC; Quentmeier H; Steube KG; Drexler HG
    Leuk Lymphoma; 1993 May; 10(1-2):135-42. PubMed ID: 8374521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of bryostatin 1 and phorbol ester on human breast cancer cell lines.
    Kennedy MJ; Prestigiacomo LJ; Tyler G; May WS; Davidson NE
    Cancer Res; 1992 Mar; 52(5):1278-83. PubMed ID: 1737390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bryostatin 1-induced hairy cell features on chronic lymphocytic leukemia cells in vitro.
    al-Katib A; Mohammad RM; Dan M; Hussein ME; Akhtar A; Pettit GR; Sensenbrenner LL
    Exp Hematol; 1993 Jan; 21(1):61-5. PubMed ID: 8093352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bryostatin 1 induces differentiation of B-chronic lymphocytic leukemia cells.
    Drexler HG; Gignac SM; Jones RA; Scott CS; Pettit GR; Hoffbrand AV
    Blood; 1989 Oct; 74(5):1747-57. PubMed ID: 2506950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of protein kinase C isoenzymes in the growth inhibition caused by bryostatin 1 in human A549 lung and MCF-7 breast carcinoma cells.
    Stanwell C; Gescher A; Bradshaw TD; Pettit GR
    Int J Cancer; 1994 Feb; 56(4):585-92. PubMed ID: 8112895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of bryostatins 1 and 2 on morphological and functional differentiation of SH-SY5Y human neuroblastoma cells.
    Jalava AM; Heikkilä J; Akerlind G; Pettit GR; Akerman KE
    Cancer Res; 1990 Jun; 50(11):3422-8. PubMed ID: 2334938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.